The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical outsourcing Market Research Report 2024
Synopsis
Pharmaceutical outsourcing has evolved from basic processes, namely bottling, to more added value techniques such as medical device engineering or R&D (research and development).
The global Pharmaceutical outsourcing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical outsourcing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical outsourcing.
Report Scope
The Pharmaceutical outsourcing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical outsourcing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical outsourcing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ABC Laboratories
Aenova
Alkermes
Associates of Cape Cod
BioPharma Solutions
Catalent Pharma Solutions
Coldstream Laboratories
Covance
Cytovance Biologics
Dalton Pharma Services
DPT Laboratories
Emergent BioSolutions
Fresenius Kabi
Grand River Aseptic Manufacturing
Halo Pharmaceutical
IGI Laboratories
Lyophilization Technology
Metrics
Mikart
Patheon
Pillar5 Pharma
Velesco Pharma
Segment by Type
Raw Material Sourcing
Active Pharmaceutical Ingredient
Finished Drugs
Segment by Application
Drug Discovery
Clinical Trials
Pre-Clinical Development
Biology Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical outsourcing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Pharmaceutical outsourcing has evolved from basic processes, namely bottling, to more added value techniques such as medical device engineering or R&D (research and development).
The global Pharmaceutical outsourcing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical outsourcing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical outsourcing.
Report Scope
The Pharmaceutical outsourcing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical outsourcing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical outsourcing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ABC Laboratories
Aenova
Alkermes
Associates of Cape Cod
BioPharma Solutions
Catalent Pharma Solutions
Coldstream Laboratories
Covance
Cytovance Biologics
Dalton Pharma Services
DPT Laboratories
Emergent BioSolutions
Fresenius Kabi
Grand River Aseptic Manufacturing
Halo Pharmaceutical
IGI Laboratories
Lyophilization Technology
Metrics
Mikart
Patheon
Pillar5 Pharma
Velesco Pharma
Segment by Type
Raw Material Sourcing
Active Pharmaceutical Ingredient
Finished Drugs
Segment by Application
Drug Discovery
Clinical Trials
Pre-Clinical Development
Biology Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical outsourcing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical outsourcing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Raw Material Sourcing
1.2.3 Active Pharmaceutical Ingredient
1.2.4 Finished Drugs
1.3 Market by Application
1.3.1 Global Pharmaceutical outsourcing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery
1.3.3 Clinical Trials
1.3.4 Pre-Clinical Development
1.3.5 Biology Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical outsourcing Market Perspective (2019-2030)
2.2 Pharmaceutical outsourcing Growth Trends by Region
2.2.1 Global Pharmaceutical outsourcing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical outsourcing Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical outsourcing Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical outsourcing Market Dynamics
2.3.1 Pharmaceutical outsourcing Industry Trends
2.3.2 Pharmaceutical outsourcing Market Drivers
2.3.3 Pharmaceutical outsourcing Market Challenges
2.3.4 Pharmaceutical outsourcing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical outsourcing Players by Revenue
3.1.1 Global Top Pharmaceutical outsourcing Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical outsourcing Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical outsourcing Revenue
3.4 Global Pharmaceutical outsourcing Market Concentration Ratio
3.4.1 Global Pharmaceutical outsourcing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical outsourcing Revenue in 2023
3.5 Pharmaceutical outsourcing Key Players Head office and Area Served
3.6 Key Players Pharmaceutical outsourcing Product Solution and Service
3.7 Date of Enter into Pharmaceutical outsourcing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical outsourcing Breakdown Data by Type
4.1 Global Pharmaceutical outsourcing Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical outsourcing Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical outsourcing Breakdown Data by Application
5.1 Global Pharmaceutical outsourcing Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical outsourcing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical outsourcing Market Size (2019-2030)
6.2 North America Pharmaceutical outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical outsourcing Market Size by Country (2019-2024)
6.4 North America Pharmaceutical outsourcing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical outsourcing Market Size (2019-2030)
7.2 Europe Pharmaceutical outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical outsourcing Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical outsourcing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical outsourcing Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical outsourcing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical outsourcing Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical outsourcing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical outsourcing Market Size (2019-2030)
9.2 Latin America Pharmaceutical outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical outsourcing Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical outsourcing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical outsourcing Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical outsourcing Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical outsourcing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ABC Laboratories
11.1.1 ABC Laboratories Company Detail
11.1.2 ABC Laboratories Business Overview
11.1.3 ABC Laboratories Pharmaceutical outsourcing Introduction
11.1.4 ABC Laboratories Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.1.5 ABC Laboratories Recent Development
11.2 Aenova
11.2.1 Aenova Company Detail
11.2.2 Aenova Business Overview
11.2.3 Aenova Pharmaceutical outsourcing Introduction
11.2.4 Aenova Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.2.5 Aenova Recent Development
11.3 Alkermes
11.3.1 Alkermes Company Detail
11.3.2 Alkermes Business Overview
11.3.3 Alkermes Pharmaceutical outsourcing Introduction
11.3.4 Alkermes Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.3.5 Alkermes Recent Development
11.4 Associates of Cape Cod
11.4.1 Associates of Cape Cod Company Detail
11.4.2 Associates of Cape Cod Business Overview
11.4.3 Associates of Cape Cod Pharmaceutical outsourcing Introduction
11.4.4 Associates of Cape Cod Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.4.5 Associates of Cape Cod Recent Development
11.5 BioPharma Solutions
11.5.1 BioPharma Solutions Company Detail
11.5.2 BioPharma Solutions Business Overview
11.5.3 BioPharma Solutions Pharmaceutical outsourcing Introduction
11.5.4 BioPharma Solutions Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.5.5 BioPharma Solutions Recent Development
11.6 Catalent Pharma Solutions
11.6.1 Catalent Pharma Solutions Company Detail
11.6.2 Catalent Pharma Solutions Business Overview
11.6.3 Catalent Pharma Solutions Pharmaceutical outsourcing Introduction
11.6.4 Catalent Pharma Solutions Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.6.5 Catalent Pharma Solutions Recent Development
11.7 Coldstream Laboratories
11.7.1 Coldstream Laboratories Company Detail
11.7.2 Coldstream Laboratories Business Overview
11.7.3 Coldstream Laboratories Pharmaceutical outsourcing Introduction
11.7.4 Coldstream Laboratories Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.7.5 Coldstream Laboratories Recent Development
11.8 Covance
11.8.1 Covance Company Detail
11.8.2 Covance Business Overview
11.8.3 Covance Pharmaceutical outsourcing Introduction
11.8.4 Covance Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.8.5 Covance Recent Development
11.9 Cytovance Biologics
11.9.1 Cytovance Biologics Company Detail
11.9.2 Cytovance Biologics Business Overview
11.9.3 Cytovance Biologics Pharmaceutical outsourcing Introduction
11.9.4 Cytovance Biologics Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.9.5 Cytovance Biologics Recent Development
11.10 Dalton Pharma Services
11.10.1 Dalton Pharma Services Company Detail
11.10.2 Dalton Pharma Services Business Overview
11.10.3 Dalton Pharma Services Pharmaceutical outsourcing Introduction
11.10.4 Dalton Pharma Services Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.10.5 Dalton Pharma Services Recent Development
11.11 DPT Laboratories
11.11.1 DPT Laboratories Company Detail
11.11.2 DPT Laboratories Business Overview
11.11.3 DPT Laboratories Pharmaceutical outsourcing Introduction
11.11.4 DPT Laboratories Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.11.5 DPT Laboratories Recent Development
11.12 Emergent BioSolutions
11.12.1 Emergent BioSolutions Company Detail
11.12.2 Emergent BioSolutions Business Overview
11.12.3 Emergent BioSolutions Pharmaceutical outsourcing Introduction
11.12.4 Emergent BioSolutions Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.12.5 Emergent BioSolutions Recent Development
11.13 Fresenius Kabi
11.13.1 Fresenius Kabi Company Detail
11.13.2 Fresenius Kabi Business Overview
11.13.3 Fresenius Kabi Pharmaceutical outsourcing Introduction
11.13.4 Fresenius Kabi Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.13.5 Fresenius Kabi Recent Development
11.14 Grand River Aseptic Manufacturing
11.14.1 Grand River Aseptic Manufacturing Company Detail
11.14.2 Grand River Aseptic Manufacturing Business Overview
11.14.3 Grand River Aseptic Manufacturing Pharmaceutical outsourcing Introduction
11.14.4 Grand River Aseptic Manufacturing Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.14.5 Grand River Aseptic Manufacturing Recent Development
11.15 Halo Pharmaceutical
11.15.1 Halo Pharmaceutical Company Detail
11.15.2 Halo Pharmaceutical Business Overview
11.15.3 Halo Pharmaceutical Pharmaceutical outsourcing Introduction
11.15.4 Halo Pharmaceutical Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.15.5 Halo Pharmaceutical Recent Development
11.16 IGI Laboratories
11.16.1 IGI Laboratories Company Detail
11.16.2 IGI Laboratories Business Overview
11.16.3 IGI Laboratories Pharmaceutical outsourcing Introduction
11.16.4 IGI Laboratories Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.16.5 IGI Laboratories Recent Development
11.17 Lyophilization Technology
11.17.1 Lyophilization Technology Company Detail
11.17.2 Lyophilization Technology Business Overview
11.17.3 Lyophilization Technology Pharmaceutical outsourcing Introduction
11.17.4 Lyophilization Technology Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.17.5 Lyophilization Technology Recent Development
11.18 Metrics
11.18.1 Metrics Company Detail
11.18.2 Metrics Business Overview
11.18.3 Metrics Pharmaceutical outsourcing Introduction
11.18.4 Metrics Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.18.5 Metrics Recent Development
11.19 Mikart
11.19.1 Mikart Company Detail
11.19.2 Mikart Business Overview
11.19.3 Mikart Pharmaceutical outsourcing Introduction
11.19.4 Mikart Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.19.5 Mikart Recent Development
11.20 Patheon
11.20.1 Patheon Company Detail
11.20.2 Patheon Business Overview
11.20.3 Patheon Pharmaceutical outsourcing Introduction
11.20.4 Patheon Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.20.5 Patheon Recent Development
11.21 Pillar5 Pharma
11.21.1 Pillar5 Pharma Company Detail
11.21.2 Pillar5 Pharma Business Overview
11.21.3 Pillar5 Pharma Pharmaceutical outsourcing Introduction
11.21.4 Pillar5 Pharma Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.21.5 Pillar5 Pharma Recent Development
11.22 Velesco Pharma
11.22.1 Velesco Pharma Company Detail
11.22.2 Velesco Pharma Business Overview
11.22.3 Velesco Pharma Pharmaceutical outsourcing Introduction
11.22.4 Velesco Pharma Revenue in Pharmaceutical outsourcing Business (2019-2024)
11.22.5 Velesco Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
